Xcout Intelモダリス
Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to…
The full profile of モダリス
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see モダリス →Already a subscriber? Sign in
Xcout Intel tracks モダリス continuously — this profile deepens as new filings, funding, people and hiring data arrive.